Assessment of vaccinations and breakthrough infections after adjustment of the dynamic zero-COVID-19 strategy in China: an online survey-Reference-Cited by-同舟云学术

Assessment of vaccinations and breakthrough infections after adjustment of the dynamic zero-COVID-19 strategy in China: an online survey

Published:2023-09-11 Issue:2 Volume:12 Page:
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Qin Shijie¹²,Li Yanhua²,Wang Likui³⁴,Zhao Xin²,Ma Xiaopeng¹,Gao George F.²⁴

Affiliation:

1. Institute of Pediatrics, Shenzhen Children’s Hospital, Shenzhen, People’s Republic of China

2. CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing, People’s Republic of China

3. CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences (CAS), Beijing, People’s Republic of China

4. International Institute of Vaccine Research and Innovation, University of Chinese Academy of Sciences (UCAS), Beijing, People’s Republic of China

Funder

China Postdoctoral Science Foundation

Bill & Melinda Gates Foundation

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2023.2258232

Reference36 articles.

1. Sera from breakthrough infections with SARS-CoV-2 BA.5 or BF.7 showed lower neutralization activity against XBB.1.5 and CH.1.1